NCT06936826 Protocol of an International Delphi Process
| NCT ID | NCT06936826 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Delphi Process |
| Study Type | OBSERVATIONAL |
| Enrollment | 23 participants |
| Start Date | 2025-04-03 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 23 participants in total. It began in 2025-04-03 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to develop a consensus-based protocol for medical screening in patients presenting with acute psychiatric symptoms. Using the Delphi method, the study seeks to identify which medical evaluations should be performed routinely in this patient population and under what circumstances. By engaging a panel of experts, the study aims to reduce variability in current practice and support the development of a standardized, evidence-informed approach.
Eligibility Criteria
Inclusion Criteria: * proficient in English * possess prior experience with medical screening processes in the Emergency Department Exclusion Criteria: \-
Contact & Investigator
Christian H Nickel, Prof. MD
STUDY CHAIR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT06936826 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Delphi Process. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06936826 currently recruiting?
Yes, NCT06936826 is actively recruiting participants. Contact the research team at Luca.Uenlue@usb.ch for enrollment information.
Where is the NCT06936826 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT06936826 clinical trial?
NCT06936826 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Christian H Nickel, Prof. MD at University Hospital, Basel, Switzerland. The trial plans to enroll 23 participants.